Market Challenges And Opportunities

Restraints & Challenges:

Increasing number of product recalls

Global Subcutaneous Drug Delivery Market – Drivers

Adoption of inorganic growth strategies by key players

Increasing focus of manufacturers on the adoption of inorganic growth strategies such as collaboration and partnership, in order to strengthen their product portfolio of subcutaneous drug delivery systems is expected to drive the market growth over the forecast period. For instance, in March 2021, the collaboration between Eitan Medical device company, provides drug delivery devices and medical pumps and Stevanato Group, a glass container manufacturing company launched a wearable injection device for the simple and efficient subcutaneous administration of large-volume and high-viscosity medications that provide the interests of both patients and pharmaceutical companies.

Increasing focus on preventing the needlestick injuries

Needlestick injuries with injection needles and lancing devices are a key concern of patients with diabetes. Insulin syringe needlestick injuries is a percutaneous wound injury caused by needle tips and can occur while using, handling, disassembling, or disposing of needles and syringes. Increasing awareness regarding safety and concern about needlestick injuries are major factors driving the growth of the subcutaneous drug delivery market.

Preference for safety injection devices is increasing among healthcare professionals and manufacturers, as these devices decrease the chances of needlestick injuries. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP) in order to prevent needlestick injuries. Moreover, in May 2021, Innovative Neurons LLC, is a medical device company has announced its plan to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology), to decrease needlestick injuries.